- Home
- FTK vs ARCT Comparison
FTK vs ARCT Comparison
Compare FTK & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTK
- ARCT
- Stock Information
- Founded
- FTK 1985
- ARCT 2013
- Country
- FTK United States
- ARCT United States
- Employees
- FTK N/A
- ARCT N/A
- Industry
- FTK Major Chemicals
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- FTK Industrials
- ARCT Health Care
- Exchange
- FTK Nasdaq
- ARCT Nasdaq
- Market Cap
- FTK 336.2M
- ARCT 320.8M
- IPO Year
- FTK N/A
- ARCT N/A
- Fundamental
- Price
- FTK $16.47
- ARCT $20.45
- Analyst Decision
- FTK Buy
- ARCT Strong Buy
- Analyst Count
- FTK 2
- ARCT 9
- Target Price
- FTK $12.00
- ARCT $50.88
- AVG Volume (30 Days)
- FTK 513.6K
- ARCT 826.4K
- Earning Date
- FTK 11-03-2025
- ARCT 11-06-2025
- Dividend Yield
- FTK N/A
- ARCT N/A
- EPS Growth
- FTK 82.12
- ARCT N/A
- EPS
- FTK 0.43
- ARCT N/A
- Revenue
- FTK $214,211,000.00
- ARCT $122,122,000.00
- Revenue This Year
- FTK $19.47
- ARCT N/A
- Revenue Next Year
- FTK $11.22
- ARCT $28.92
- P/E Ratio
- FTK $41.21
- ARCT N/A
- Revenue Growth
- FTK 21.72
- ARCT N/A
- 52 Week Low
- FTK $4.70
- ARCT $8.04
- 52 Week High
- FTK $17.89
- ARCT $24.13
- Technical
- Relative Strength Index (RSI)
- FTK 67.17
- ARCT 56.73
- Support Level
- FTK $15.02
- ARCT $20.08
- Resistance Level
- FTK $17.93
- ARCT $23.60
- Average True Range (ATR)
- FTK 1.10
- ARCT 1.68
- MACD
- FTK 0.39
- ARCT -0.00
- Stochastic Oscillator
- FTK 75.92
- ARCT 51.25
About FTK Flotek Industries Inc.
Flotek Industries Inc is a technology-driven specialty chemistry and data company. It has two reportable segments: Its Chemistry Technologies segment includes specialty chemistries, logistics and technology services. It also include integrated oil and gas companies, oilfield services companies, independent oil and gas companies, national and state-owned oil companies, and international supply chain management companies. The Data Analytics segment provides analytical measurement solutions and deliver real-time information and insights to customers to enable optimization of operations and reduction of emissions and their carbon intensity. Key revenue comes from its Chemistry Technologies segment.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.